Bridging the interface between common conditions and rare diseases through an app-based clinical decision aid.

Led by the South East GMSA with tech development by UBQO, QGenome aims to facilitate genomic testing of common conditions and rare diseases through an app-based clinical decision aid.

QGenome’s ever expanding library and workstreams walk clinicians through specialty areas such as cardiac, renal, cancer, and midwifery. As evidence-based recommendations and the National Test Directory advances, our teams of experts update the app seamlessly.

In September 2022, we began a pilot expansion into North Thames and East of England, with the North Thames GMSA and East GMSA respectively. In the future, our ambition is for QGenome to expand into all GMSA regions.

QGenome is available on iOS and Android devices and as a web app. For download, more information, FAQs, and thought-provoking blog posts and content, please visit the QGenome website.

Critical incident affecting genomics tests from Viapath

The issues with our IT systems have now been resolved  and our laboratory is processing all tests and referrals sent to us.

Please be aware that as normal services resume you may experience some delays to receiving results and the reports may look different.

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.